These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3677071)

  • 1. Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
    Kozak S; Rizzoli R; Trechsel U; Fleisch H
    Cancer Res; 1987 Dec; 47(23):6193-7. PubMed ID: 3677071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
    Rosol TJ; Capen CC
    J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound.
    Green JR; Müller K; Jaeggi KA
    J Bone Miner Res; 1994 May; 9(5):745-51. PubMed ID: 8053405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Walker 256/B carcinosarcoma in thyroparathyroidectomized rats: a model to evaluate inhibitors of bone resorption.
    Rizzoli R; Fleisch H
    Calcif Tissue Int; 1987 Oct; 41(4):202-7. PubMed ID: 2960427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption in vivo.
    Trechsel U; Stutzer A; Fleisch H
    J Clin Invest; 1987 Dec; 80(6):1679-86. PubMed ID: 3680521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.
    Lin JH; Chen IW; deLuna FA; Hichens M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):670-5. PubMed ID: 8246140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
    Weiss J; Walker ST; Fallon M; Goldfarb S
    J Pharmacol Exp Ther; 1986 Sep; 238(3):969-73. PubMed ID: 3018229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
    Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
    BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiresorptive dose-response relationships across three generations of bisphosphonates.
    Sietsema WK; Ebetino FH; Salvagno AM; Bevan JA
    Drugs Exp Clin Res; 1989; 15(9):389-96. PubMed ID: 2630251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative role of bone and kidney in the hypercalcaemia associated with the rat Walker carcinosarcoma 256.
    Hurtado J; Esbrit P; Rapado A
    Eur J Cancer; 1991; 27(1):76-9. PubMed ID: 1849415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral tibial marrow ablation in rats induces a rapid hypercalcemia arising from extratibial bone resorption inhibitable by methylprednisolone or deflazacort.
    Magnuson SK; Booth R; Porter S; Gorski JP
    J Bone Miner Res; 1997 Feb; 12(2):200-9. PubMed ID: 9041051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone-like changes in renal calcium and phosphate reabsorption induced by Leydig cell tumor in thyroparathyroidectomized rats.
    Rizzoli R; Caverzasio J; Fleisch H; Bonjour JP
    Endocrinology; 1986 Sep; 119(3):1004-9. PubMed ID: 3755393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypercalcemic activity of Walker carcinosarcoma 256 in the rat].
    Minne H; Ziegler R; Schmitt W; Hilgard P
    Schweiz Med Wochenschr; 1971 Apr; 101(13):481-3. PubMed ID: 5558917
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical treatment of malignant hypercalcemia].
    Eto S; Nakano Y; Okada Y
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2311-8. PubMed ID: 8259844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects of a single dose of bisphosphonates on retinoid-induced bone resorption in thyroparathyroidectomized rats.
    Stutzer A; Fleisch H; Trechsel U
    Calcif Tissue Int; 1988 Nov; 43(5):294-9. PubMed ID: 3145796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of diphosphonates in the treatment of hypercalcemia in multiple myeloma: efficacy of 4-amino-hydroxybutylidene-1,1-bisphosphonate (AHButBP)].
    Attardo-Parrinello G; Crema F; Merlini G; Spaghi A; Fiorentini ML
    Medicina (Firenze); 1988; 8(1):75-6. PubMed ID: 3226251
    [No Abstract]   [Full Text] [Related]  

  • 18. Bisphosphonates in the treatment of disorders of mineral metabolism.
    Singer FR; Minoofar PN
    Adv Endocrinol Metab; 1995; 6():259-88. PubMed ID: 7671099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of bisphosphonates on vitamin A-induced bone resorption in thyroparathyroidectomized rat].
    Gen M
    Nihon Seikeigeka Gakkai Zasshi; 1995 Nov; 69(11):1193-207. PubMed ID: 8568374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.